![]() |
市场调查报告书
商品编码
1702200
2025 年至 2033 年压力袜市场报告,按产品类型(及膝袜、大腿袜)、人口统计(男性、女性)、配销通路(线下、线上)和地区划分Compression Stockings Market Report by Product Type (Knee High, Thigh High), Demography (Men, Women), Distribution Channel (Offline, Online), and Region 2025-2033 |
2024 年全球压力袜市场规模达 17 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 25 亿美元,2025-2033 年期间的成长率 (CAGR) 为 4.23%。市场的主要驱动力是静脉疾病盛行率的不断上升、人们对健康意识的不断增强以及人口老化的不断增加。此外,人们对压力疗法益处的认识不断提高,进一步鼓励人们采用这些袜子,从而促进市场成长。
压力袜对脚踝和小腿施加轻柔的压力,以改善血液流动,抑制血栓形成并减轻疼痛。因此,它们有助于预防水肿、淋巴水肿、静脉炎、蜘蛛静脉和静脉曲张以及深部静脉栓塞 (DVT)。它们还有助于改善怀孕期间与静脉功能不全相关的下肢症状。除此之外,它们还可以作为直立性低血压(OH)患者的非药物治疗选择。一些常用的压力袜包括渐进式压力袜(GCS)、抗栓塞袜和非医用支持袜。
慢性静脉疾病 (CVD) 普遍存在,诊断不足,并可能发展为慢性静脉功能不全 (CVI) 和静脉性腿部溃疡 (VLU),需要大量治疗和住院。再加上久坐不动的生活方式导致肥胖症的日益流行,这是推动市场成长的关键因素之一。除此之外,使用压力袜的压迫疗法有助于治疗下肢静脉溃疡,因为它可以促进溃疡癒合、减轻疼痛并防止復发。它还有助于缩小静脉,恢復瓣膜功能,最大限度地降低动态静脉压力,并减少静脉回流(VR)。此外,它有助于减少发炎细胞因子和降低毛细血管液体渗漏,从而减轻肢体水肿。此外,领先的参与者越来越注重积极的促销活动,向跑步者、铁人三项运动员和其他耐力运动员宣传压力袜。这些长袜可以增强体力活动期间的血液循环,提高运动表现,并促进快速恢復。这与蓬勃发展的体育产业一起,提高了整体销售额和获利能力。此外,预计全球老年人口的增加将推动市场成长。
The global compression stockings market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033. The market is majorly driven by the growing prevalence of venous disorders, rising awareness about health and wellness, and an increasing aging population. Additionally, steadily rising awareness regarding the benefits of compression therapy is further encouraging adoption of these stocking, thereby contributing to the market growth.
Compression stockings apply gentle pressure over the ankles and calves to improve blood flow, inhibit the formation of blood clots, and reduce pain. As a result, they help prevent edema, lymphedema, phlebitis, spider and varicose veins, and deep vein thrombosis (DVT). They also aid in improving lower extremity symptoms associated with venous insufficiency during pregnancy. Besides this, they can be used as a non-pharmacological treatment option for individuals with orthostatic hypotension (OH). Some of the commonly used compression stockings include graduated compression stockings (GCS), anti-embolism stockings, and non-medical support hosiery.
Chronic venous disease (CVD) is widespread, underdiagnosed, and can progress to chronic venous insufficiency (CVI) and venous leg ulcers (VLU), which require extensive treatment and hospitalization. This, coupled with the rising prevalence of obesity on account of sedentary lifestyles, represents one of the key factors bolstering the growth of the market. Besides this, compression therapy using compression stockings assists in the treatment of VLU as it results in ulcer healing, reduction of pain, and prevention of recurrence. It also helps narrow veins, restore valve competence, minimize ambulatory venous pressure, and reduce venous reflux (VR). In addition, it aids in decreasing inflammatory cytokines and lowering capillary fluid leakage, thereby alleviating limb edema. Moreover, leading players are increasingly focusing on aggressive promotional activities for advertising compression stockings to runners, triathletes, and other endurance athletes. These stockings enhance blood circulation during physical activity, boost athletic performance, and enable rapid recovery. This, along with the burgeoning sports industry, is augmenting the overall sales and profitability. Furthermore, the increasing geriatric population around the world is projected to fuel the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being 2XU Pty Ltd., Bauerfeind AG, Belsana, Creswell Sock Mills, DJO LLC (Enovis Corporation), Gloria Med Spa, Manifattura Cizeta s.r.l., medi GmbH & Co. KG, Sigvaris AG (Sigvaris Management AG), Spanx Inc., Thuasne and Triumph Home Health Supplies.